AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Venlor-XR 37.5 Capsule

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Venlafaxine (37.5mg)

Overview Venlor-XR 37.5 Capsule

Desvenlafaxine succinate 37.5mg extended-release capsules treat depressive and anxiety disorders. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, hyperactivity, poor concentration, tiredness, perspiration, tachycardia, and racing thoughts. Take Desvenlafaxine succinate 37.5mg extended-release capsules with food, at the same time daily for consistent blood levels. If a dose is missed, take it immediately upon recall; avoid skipping doses and complete the prescribed course, even with symptom improvement. Abrupt cessation is discouraged, as it can exacerbate symptoms. Common side effects include nausea, vomiting, sleep disturbances, reduced appetite, heightened anxiety, constipation, diaphoresis, and sexual dysfunction. Dizziness and somnolence may occur; avoid driving or mentally demanding tasks until the effects are known. These side effects are generally transient and self-limiting. Consult your physician if they persist or are bothersome. Before initiating treatment, disclose any kidney, heart, or liver conditions, or history of seizures. Report any unusual mood or behavioral changes, worsening depression, or suicidal ideation to your doctor.

Uses of Venlor-XR 37.5 Capsule

Mood disorders encompassing depressive and anxious symptoms

Major Benefits of Venlor-XR 37.5 Capsule:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Ingest Venlor-XR 37.5mg capsules with a meal.

Common Side effects of Venlor-XR 37.5 Capsule:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Venlor-XR 37.5 Capsule:

Follow your physician's instructions or consult the product information leaflet for usage guidance. Ingestion of Venlor-XR 37.5mg capsules should coincide with a meal.

How Venlor-XR 37.5 Capsule works:

Extended-release Venlor 37.5mg capsules elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Venlor-XR 37.5mg capsules with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Venlor-XR 37.5mg capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Venlor-XR 37.5 mg capsules while breastfeeding is likely unsafe. Studies in humans indicate the medication may transfer to breast milk, posing a potential risk to the infant. Close observation of newborns for sufficient weight gain and any signs of excessive drowsiness is advised.

DrivingDrivingUNSAFE

Driving ability may be impaired by Venlor-XR 37.5mg capsules due to potential side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can impact driving safety.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Venlor-XR 37.5 mg capsules; dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Venlor-XR 37.5 mg capsules. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Venlor-XR 37.5 Capsule :

Should you forget a Venlor-XR 37.5mg capsule, take it immediately. However, near your next scheduled dose, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Venlor-XR 37.5 Capsule

LabelValue
Chemical Category Anisole-based compound
Developing Habits No.
Treatment Category Neuroscience Central Nervous System
Action Class SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Venlor-XR 37.5 Capsule

Yes, Venlor-XR 37.5mg capsules can cause drowsiness. Inform your doctor about any other sleep aids you're taking before starting this medication.
Yes. Venlor-XR 37.5mg capsules are psychotropic medications; these medications affect mental processes, emotions, and behavior.
Venlor-XR 37.5 Capsules are not narcotics. Narcotics are opioid-derived drugs, such as heroin and morphine, known for their sedative effects.
Venlor-XR 37.5mg capsules, whether labeled ER or XR, are identical extended-release formulations. This slow release ensures consistent medication levels, reducing the required dosing frequency.
Mirtazapine and Venlor-XR 37.5 capsules together pose a serious risk of serotonin syndrome, a potentially life-threatening condition. Symptoms can include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high body temperature, and coma.
Combining citalopram and Venlor-XR 37.5 mg capsules elevates serotonin levels, risking serotonin syndrome—a potentially fatal condition. Symptoms may include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma. An alternative medication should be considered.
P-glycoprotein pumps Venlor-XR 37.5 Capsule out of the brain. However, some research indicates that Venlor-XR 37.5 Capsule and its metabolite can inhibit p-glycoprotein.
Venlor-XR 37.5 mg capsules are absorbed into the body via the intestines following hepatic metabolism.
Venlor-XR 37.5mg capsules treat generalized anxiety disorder and depression. Always consult a physician before use.
Venlor-XR 37.5 Capsule may cause sustained blood pressure increases in some patients. Regular blood pressure monitoring is recommended for those taking this medication; dose reduction or discontinuation may be necessary.
Yes, constipation is a known side effect of Venlor-XR 37.5mg capsules in some individuals. Increase your fiber intake and fluid consumption. Laxatives may also be helpful. Your doctor can provide additional guidance on prevention and management. Consult your physician if constipation persists or worsens.
Yes, some patients taking Venlor-XR 37.5mg capsules experience weight loss, observed as dose-dependent in clinical trials. Consult your doctor if this concerns you.
Venlor-XR 37.5 mg capsules are not considered habit-forming.
Consult your doctor before substituting tablets for capsules. Altering your medication without professional guidance is risky, as different formulations affect drug release and may cause treatment inefficacy, side effects, or even treatment failure.
Yes, gabapentin can be used concurrently with Venlor-XR 37.5mg capsules, but only under a doctor's supervision. Combined use may increase drowsiness, sleepiness, and impair concentration. Exercise caution.
Desvenlafaxine is the active ingredient in Venlor-XR 37.5 mg capsules.
Venlor-XR 37.5 mg capsules are not FDA-approved for fibromyalgia, although some studies suggest potential benefits. Always consult your physician before using this medication for fibromyalgia.
While not FDA-approved for nerve pain, Venlor-XR 37.5mg capsules demonstrate efficacy in some research studies and are therefore sometimes used off-label for this condition.
Venlor-XR 37.5 mg capsules can alter brain neurotransmitter levels, resulting in decreased appetite, an effect that increases with higher doses.
Experience decreased libido or impotence? Consult your doctor to explore alternative medications. Never discontinue Venlor-XR 37.5 Capsule without medical supervision; doing so may worsen side effects.
Venlor-XR 37.5 Capsule
57
MRP 66
13% off